Progenics Pharmaceuticals Inc. (PGNX) Stock Price, Quote ... Find the latest Progenics Pharmaceuticals Inc. (PGNX) stock quote, history, news and other vital information to help you with your stock trading and investing. Progenics Pharmaceuticals Inc. (PGNX) Analyst Ratings ... See Progenics Pharmaceuticals Inc. (PGNX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Progenics Pharmaceuticals Inc. - PGNX - Stock Price Today ...
View today's stock price, news and analysis for Progenics Pharmaceuticals Inc. (PGNX). Barron's also provides information on historical stock ratings, target prices, company earnings, market
PGNX | Progenics Pharmaceuticals Inc. Analyst Estimates ... Nov 09, 2019 · Progenics Pharmaceuticals Inc. analyst estimates by MarketWatch. View PGNX revenue estimates and earnings estimates, as well as analyst recommendations. Progenics Pharmaceuticals Inc. Common Stock (PGNX) Stock ... Progenics Pharmaceuticals Inc. Common Stock (PGNX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Progenics Pharmaceuticals Inc. (PGNX) Balance Sheet ...
View Progenics Pharmaceuticals, Inc.'s fair value, stock price, financial statements, news, valuation models, 12 days agofinance.yahoo.comPGNX
PGNX Stock Quote - Progenics Pharmaceuticals Inc. Common ... Mar 27, 2020 · Stock quote for Progenics Pharmaceuticals Inc. Common Stock Common Stock (PGNX) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.
View PGNX stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst. Price To Book 6.26. Market Cap
PGNX Stock Price Quote & News - Progenics Pharmaceuticals ... View the real-time PGNX price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Progenics Pharmaceuticals against related stocks people have also bought like GERN, VKTX, VSTM, and TEVA. 2,069 people own Progenics Pharmaceuticals on Robinhood on April 4, 2020. Here's Why Shares of Progenics Pharmaceuticals Inc. Sank ... Shares of Progenics Pharmaceuticals (NASDAQ:PGNX) are down 16.8% at 12:07 p.m. EDT after releasing disappointing top-line data for the phase 3 clinical trial testing its prostate cancer imaging
Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings,
Progenics Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PGNX updated stock price target summary.